Search research articles
Contact Us
Filters
Showing results (421-430 of 577) with videos related to
Page
of 58
Sort By:
European Journal of Medicinal Chemistry
|
May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarials
Shane M Devine, Matthew P Challis, Jomo K Kigotho, et al.
ACS Applied Bio Materials
|
January 8, 2022
Synthesis and in Vivo Behavior of PVP/CMC/Agar Hydrogel Membranes Impregnated with Silver Nanoparticles for Wound Healing Applications
Gabriel G de Lima, Darlla W F de Lima, Maria J A de Oliveira, et al.
Frontiers in Immunology
|
October 7, 2022
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program
Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, et al.
Blood
|
March 6, 2002
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia
Steven M Devine, Ron Hoffman, Amit Verma, et al.
The Laryngoscope
|
July 17, 2023
Modulated Fibrosis and Mechanosensing of Fibroblasts by SB525334 in Pediatric Subglottic Stenosis
Soheila Ali Akbari Ghavimi, Matthew R Aronson, Daniel D Ghaderi, et al.
Leukemia & Lymphoma
|
September 11, 2013
Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia
Rebecca B Klisovic, William Blum, Zhongfa Liu, et al.
Cancer
|
December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study
Jonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
Ginna G Laport, Juan Wu, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
Human Gene Therapy
|
August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
A Bartholomew, S Patil, A Mackay, et al.
Page
of 58
Search research articles
Search
Showing results (421-430 of 577) with videos related to
Sort By:
Page
of 58
European Journal of Medicinal Chemistry
|
May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarials
Shane M Devine, Matthew P Challis, Jomo K Kigotho, et al.
ACS Applied Bio Materials
|
January 8, 2022
Synthesis and in Vivo Behavior of PVP/CMC/Agar Hydrogel Membranes Impregnated with Silver Nanoparticles for Wound Healing Applications
Gabriel G de Lima, Darlla W F de Lima, Maria J A de Oliveira, et al.
Frontiers in Immunology
|
October 7, 2022
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program
Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, et al.
Blood
|
March 6, 2002
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia
Steven M Devine, Ron Hoffman, Amit Verma, et al.
The Laryngoscope
|
July 17, 2023
Modulated Fibrosis and Mechanosensing of Fibroblasts by SB525334 in Pediatric Subglottic Stenosis
Soheila Ali Akbari Ghavimi, Matthew R Aronson, Daniel D Ghaderi, et al.
Leukemia & Lymphoma
|
September 11, 2013
Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia
Rebecca B Klisovic, William Blum, Zhongfa Liu, et al.
Cancer
|
December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study
Jonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
Ginna G Laport, Juan Wu, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
Human Gene Therapy
|
August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
A Bartholomew, S Patil, A Mackay, et al.
Page
of 58